Medtronic's Q4 Earnings: Medical Device Giant Clocks Strong Sales From Neurology Devices, Hikes Dividend
Portfolio Pulse from Vandana Singh
Medtronic Plc (NYSE:MDT) reported strong Q4 2024 earnings, with sales of $8.59 billion beating consensus estimates. The company saw broad-based organic revenue growth across all segments and increased its quarterly dividend. Despite positive results, MDT shares are down 2.64%.
May 23, 2024 | 3:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic reported Q4 2024 sales of $8.59 billion, beating consensus estimates. The company saw broad-based organic revenue growth and increased its quarterly dividend. Despite these positive results, MDT shares are down 2.64%.
Medtronic's strong earnings report and dividend hike are positive indicators for the company's financial health and future growth. However, the immediate market reaction has been negative, with shares down 2.64%. This could be due to profit-taking or broader market conditions.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100